Literature DB >> 19693700

Association and impact of XPG Asp 1104 His gene polymorphism in HIV 1 disease progression to AIDS among north Indian HIV seropositive individuals.

Ranbir Chander Sobti1, Nega Berhane, Salih Abedule Mehedi, Rupinder Kler, Seyed Ali Hosseini, Vijish Kuttiat, Ajay Wanchu.   

Abstract

Various efforts made to stop the deadly epidemic of HIV since its discovery in 1983 remain unsuccessful and this virus still continues to claim the lives of millions of individuals every year. The viral effect in the cell is complicated and the overall disease outcome is the result of interaction between a few viral proteins and complex host immune response. Because it has been reported that XPG (Xeroderma pigementesum group G) gene does play a role in reducing UV induced apoptosis and participate in Nucleotide Excision Repair (NER) process of DNA damage, it was hypothesized that polymorphism in this gene may have a role in HIV 1 disease progression to AIDS. The aim of the present study, therefore, was to find out the association between XPG gene polymorphism and its effect on the rate of HIV 1 disease progression to AIDS. 300 HIV seropositive cases and an equal number of age and sex matched controls were recruited for the study from north Indian population. The PCR-RFLP method was utilized to genotype 600 study subject for the XPG Asp (1104) His gene polymorphism. There was significant difference in the frequency of the His/His variant genotype (OR 1.95, 95% CI = 1.93-3.63, P = 0.04) between cases and controls indicating a probable role of this gene in host viral interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693700     DOI: 10.1007/s11033-009-9698-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

Review 1.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

2.  DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1.

Authors:  Mohamed Hamdi; Jaap Kool; Paulien Cornelissen-Steijger; Francoise Carlotti; Herman E Popeijus; Corina van der Burgt; Josephine M Janssen; Akira Yasui; Rob C Hoeben; Carrol Terleth; Leon H Mullenders; Hans van Dam
Journal:  Oncogene       Date:  2005-11-03       Impact factor: 9.867

3.  HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 alpha in vitro.

Authors:  L Weiss; N Haeffner-Cavaillon; M Laude; J Gilquin; M D Kazatchkine
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

4.  Programmed death of T cells in HIV-1 infection.

Authors:  L Meyaard; S A Otto; R R Jonker; M J Mijnster; R P Keet; F Miedema
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

Review 5.  Elite HIV controllers: myth or reality?

Authors:  Nitin K Saksena; Berta Rodes; Bin Wang; Vincent Soriano
Journal:  AIDS Rev       Date:  2007 Oct-Dec       Impact factor: 2.500

6.  Suboptimal DNA repair capacity predisposes coke-oven workers to accumulate more chromosomal damages in peripheral lymphocytes.

Authors:  Juan Cheng; Shuguang Leng; Haishan Li; Chuanfeng Huang; Yong Niu; Linyuan Zhang; Xuemiao Liang; Han Lin; Yuxin Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

7.  DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma.

Authors:  Miwa Sasaki; Shigeru Sakano; Naoko Okayama; Jumpei Akao; Tomohiko Hara; Yoshihisa Kawai; Chietaka Ohmi; Yuji Hinoda; Katsusuke Naito
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

8.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

Review 9.  Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Int J Med Sci       Date:  2007-02-01       Impact factor: 3.738

10.  Predictors of disease progression in HIV infection: a review.

Authors:  Simone E Langford; Jintanat Ananworanich; David A Cooper
Journal:  AIDS Res Ther       Date:  2007-05-14       Impact factor: 2.250

View more
  5 in total

1.  A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.

Authors:  Lidan Xu; Yuandong Qiao; Xuelong Zhang; Haiming Sun; Jingwei Wang; Donglin Sun; Xueyuan Jia; Chao Shen; Yanling Zhao; Yan Jin; Yang Yu; Hong Ling; Kaili Wang; Songbin Fu
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

2.  DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population.

Authors:  Nega Berhane; Rabinder Chandera Sobti; Salih Abdul Mahdi
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

3.  Association of xeroderma pigmentosum complementation group G Asp1104His polymorphism with breast cancer risk: A cumulative meta-analysis.

Authors:  Xiao-Ming Xu; Long-Chuan Xie; Ling-Ling Yuan; Xiao-Li Hu; Jian-Qiang Jin; Yu-Ming Niu
Journal:  Mol Clin Oncol       Date:  2014-08-11

4.  Association of interleukin 4 VNTR polymorphism and HIV/AIDS in a north Indian seropositive patients.

Authors:  Ranbiden Chandera Sobti; Nega Berhane; Salih Abdul Mahdi; Hitnder Takur; Ajay Wanch
Journal:  Mol Biol Rep       Date:  2011-06-29       Impact factor: 2.316

5.  Relationship between the Asp1104His polymorphism of the nucleotide excision repair gene ERCC5 and treatment sensitivity to oxaliplatin in patients with advanced colorectal cancer in China.

Authors:  Jiangying Kong; Zhuo Liu; Feng Cai; Xiaocheng Xu; Jun LiuI
Journal:  Clinics (Sao Paulo)       Date:  2018-12-03       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.